These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 702453)

  • 1. Oral contraceptives, venous thrombosis, and varicose veins. Royal College of General Practitioners' Oral Contraception Study.
    J R Coll Gen Pract; 1978 Jul; 28(192):393-9. PubMed ID: 702453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
    Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral contraception and circulatory risks].
    Wingrave SJ
    Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1111-6. PubMed ID: 12266560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for fatal venous thromboembolism in young women: a case-control study.
    Thorogood M; Mann J; Murphy M; Vessey M
    Int J Epidemiol; 1992 Feb; 21(1):48-52. PubMed ID: 1544757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.
    J R Coll Gen Pract; 1983 Feb; 33(247):75-82. PubMed ID: 6864638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral contraceptives: APF takes a position].
    Sex Planeam Fam; 1995; (7):17-8. PubMed ID: 12179267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood changes in sex steroid hormone users. Circulating immune complexes induced by estrogens and progestogens and their relation to vascular thrombosis.
    Beaumont V; Delplanque B; Lemort N; Beaumont JL
    Atherosclerosis; 1982 Sep; 44(3):343-53. PubMed ID: 7150397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical embolism associated with oral contraceptives: an underdiagnosed lesion?
    de Swiet J
    Postgrad Med J; 1979 Jun; 55(644):419-20. PubMed ID: 482190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The choice of oral contraception in 1984: general indications and specific cases].
    Gaspard U
    Rev Med Liege; 1984 Apr; 39(7):261-5. PubMed ID: 6729293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of estrogens and progesterone on the venous system of the lower limbs in women.
    Vin F; Allaert FA; Levardon M
    J Dermatol Surg Oncol; 1992 Oct; 18(10):888-92. PubMed ID: 1430544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.